SEC Form 4 · accession 0001104659-15-001881
Radius Health, Inc. · RDUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owners
Katherine Priestley
10% Owner
F2 Bioscience III, L.P.
10% Owner
F2 Capital Ltd
10% Owner
F2 Bioscience GP Ltd.
10% Owner
Period of report
Jan 8, 2015
Accepted (ET)
Jan 12, 2015 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428522
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 8, 2015 | J | 389,331 | — | D | 1,167,997 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock WarrantF1,F2 | $2.694 | Jan 8, 2015 | J | 89,261 | D | Apr 23, 2013 | Apr 23, 2018 | Common Stock | 89,261 | 267,786 | D |
Explanation of responses
- F1Reflects a distribution by the Reporting Person to a limited partner pursuant to a discretionary election.
- F2The reported securities are owned directly by F2 Bioscience III, L.P. ("F2"). Each of F2 Biosciences GP Ltd. ("F2 GP"), Katherine Priestley and F2 Capital Limited ("F2 Capital") are indirect beneficial owners of the reported securities. F2 GP is the General Partner of F2 and Katherine Priestley is a member of F2 GP. F2 Capital is an investment adviser to F2. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.